U.S. Wireless Telecom Stock News

NasdaqCM:AHG
NasdaqCM:AHGHealthcare

Akso Health Group (AHG) Valuation Check As Shares Hit A New 52 Week High On Strong Revenue Growth

Akso Health Group (AHG) recently hit a new 52 week high at US$2.10, alongside reported 75.6% revenue growth and a 30% total return over the past year, despite a thin 1% gross margin. See our latest analysis for Akso Health Group. The latest move to US$2.42 comes after a strong run, with an 84.7% 1 month share price return and a 51.3% year to date share price return. The 1 year total shareholder return of 92.1% and very large 3 year total shareholder return suggest momentum has been building...
NYSE:RHLD
NYSE:RHLDProfessional Services

Assessing Resolute Holdings Management (RHLD) Valuation After Recent Share Price Pullback

Resolute Holdings Management (RHLD) has drawn fresh attention after recent trading left the stock with a 9% decline over the past month and a 24% decline over the past three months, sharpening focus on its valuation profile. See our latest analysis for Resolute Holdings Management. Despite the recent 30 day and 90 day share price returns of 8.6% and 24.6% declines, respectively, the 1 year total shareholder return of about 3.7x and the latest $164.17 share price point to fading short term...
NYSE:ARX
NYSE:ARXInsurance

Accelerant Holdings (ARX) Revenue Surges To US$326.9 Million Challenging Bearish Loss Narratives

Accelerant Holdings (ARX) closed FY 2025 with fourth quarter revenue of US$326.9 million and a basic EPS loss of US$0.0027, while the trailing twelve month figures showed revenue of US$912.9 million and a basic EPS loss of US$7.49. Over recent periods, the company has seen quarterly revenue move from US$181.2 million in Q4 2024 to US$163.5 million in Q1 2025, US$204.7 million in Q2 2025, US$217.8 million in Q3 2025 and US$326.9 million in Q4 2025, with EPS shifting from US$10.57 in Q4 2024 to...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

A Look At Protagonist Therapeutics (PTGX) Valuation After ICOTYDE Receives U.S. FDA Approval

FDA approval sets new context for Protagonist Therapeutics The recent U.S. FDA approval of ICOTYDE for moderate to severe plaque psoriasis is a major regulatory milestone for Protagonist Therapeutics (PTGX). This development is putting fresh attention on the company’s commercial potential and broader pipeline. See our latest analysis for Protagonist Therapeutics. The FDA approval has arrived after a strong run in the shares, with a 23.31% 1 month share price return and a 91.67% 1 year total...
NasdaqCM:LE
NasdaqCM:LESpecialty Retail

Lands' End (LE) Q4 EPS Rebound Tests Bullish Margin Expansion Narrative

Lands' End (LE) has rounded out FY 2026 with Q4 revenue of US$462.4 million and basic EPS of US$0.40, supported by net income of US$12.3 million. Over recent quarters, the company has seen revenue move from US$261.2 million in Q1 2026 to US$317.5 million in Q3 2026 before reaching US$462.4 million in Q4. Quarterly EPS shifted from a loss of US$0.27 in Q1 to a profit of US$0.40 in Q4. For investors, the focus now is on how sustainable these earnings are given the thin trailing net profit...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

Is Jack Henry And Associates (JKHY) Fairly Priced After Recent Share Price Weakness?

Wondering if Jack Henry & Associates is priced attractively or already fully valued at around US$164 a share? This article breaks down what that current price might imply about the stock. The share price has moved by a 1.1% decline over the last week, a 3.7% gain over the last 30 days, and a 7.8% decline year to date, with a 4.9% decline over the last year and returns of 16.7% over three years and 14.6% over five years. That mix of shorter term weakness and longer term gains provides context...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

Is It Time To Reassess Steel Dynamics (STLD) After Recent Tariff Headlines And Price Pullback

If you are wondering whether Steel Dynamics at around US$167.56 is offering fair value or not, the key is to separate short term noise from the longer term valuation picture. The share price has seen a 4.3% decline over the last 7 days and a 12.7% decline over the last 30 days, even though the 1 year return sits at 34.2% and the 5 year return is 281.7%. Recent news coverage has focused on Steel Dynamics as a major US steel producer, with attention on how its capital allocation, capacity...
NYSE:VRT
NYSE:VRTElectrical

Is It Too Late To Look At Vertiv Holdings Co (VRT) After Its 200% One Year Surge?

Curious whether Vertiv Holdings Co at around US$269 per share is still offering value after such a strong run, or if you are late to the story. The stock has recently posted returns of 1.4% over 7 days, 10.5% over 30 days, 53.3% year to date and 202.5% over the last year, with a very large 3 year gain and strong 5 year performance. Recent coverage has focused on Vertiv as a key player supplying critical power and cooling infrastructure for data centers and AI related workloads, which has...
NYSE:NU
NYSE:NUBanks

Is It Too Late To Consider Nu Holdings (NU) After Recent Share Price Pullback?

If you are wondering whether Nu Holdings at US$14.16 still offers value or if most of the easy gains are already behind it, this article walks through what the current price might be implying. The stock is up 1.4% over the past week, while showing a 15.8% decline over the last month and a 16.8% decline year to date, set against a 24.2% return over the past year and a very large three-year gain of around 3x. Recent coverage of Nu Holdings has focused on its position as a fast-growing digital...
NYSE:COTY
NYSE:COTYPersonal Products

A Look At Coty (COTY) Valuation After Recent Share Price Weakness

Assessing Coty after recent share price pressure Coty (COTY) has come under pressure recently, with the share price showing negative returns over the past month, past 3 months and year. For investors, the key question is whether current levels fairly reflect its fundamentals. See our latest analysis for Coty. At a share price of US$2.15, Coty’s recent 30 day share price return of a 16.02% decline and year to date share price return of a 30.87% decline point to fading momentum and a weaker 1...
NasdaqCM:EOSE
NasdaqCM:EOSEElectrical

A Look At Eos Energy Enterprises (EOSE) Valuation After Class Action Lawsuit And Guidance Shortfall

What Triggered The Latest Focus On Eos Energy Enterprises (EOSE)? A new class action lawsuit against Eos Energy Enterprises (EOSE) has sharpened attention on the stock after allegations that earlier statements about production capabilities and financial guidance did not match later disclosures. The suit follows the company’s fourth quarter and full year 2025 update, where reported revenue of US$114.2 million was below prior guidance and management outlined production inefficiencies and...
NYSE:HIG
NYSE:HIGInsurance

Assessing Hartford (HIG) Valuation After Recent Share Price Pullback And Undervaluation Debate

Why Hartford Insurance Group (HIG) is on investors’ radar today Hartford Insurance Group (HIG) has drawn fresh attention after recent trading left the shares with a 1 day return of about a 1% decline and a month move near an 8% decline. That short term pullback sits against a 1 year total return of about 12% and multi year total returns above 100%. This has prompted some investors to reassess what the current US$131.36 share price implies. See our latest analysis for Hartford Insurance...
NYSE:ICE
NYSE:ICECapital Markets

Is It Time To Reassess Intercontinental Exchange (ICE) After Recent Share Price Weakness

Wondering whether Intercontinental Exchange at around US$158.50 is starting to look attractively priced, or if the stock still has more optimism baked in than the numbers support. The share price has moved only slightly over the last week with a 0.1% decline, while the 30 day return sits at 3.3%, the year to date return is a 0.9% decline, and the 1 year return is an 8.7% decline. These figures compare with a 70.5% return over 3 years and 50.6% over 5 years. Recent coverage has focused on how...
NYSE:XIFR
NYSE:XIFRRenewable Energy

XPLR Infrastructure (XIFR) Valuation Check After Evercore Downgrade And New NextEra Battery Co Investment

Recent moves around XPLR Infrastructure (NYSE:XIFR) have centred on an Evercore ISI downgrade linked to its ongoing restructuring, along with new clean energy plans that include expanded repowering capacity and new battery co-investments with NextEra Energy. See our latest analysis for XPLR Infrastructure. Those restructuring headlines appear to be landing in a mixed way with investors, with a 1 day share price return of negative 1.53% and a 7 day share price return of negative 3.30%, while...
NYSE:MO
NYSE:MOTobacco

Altria Faces Certified Antitrust Classes As E Vapor Risks Intensify

U.S. District Court certifies consumer antitrust class actions against Altria Group and Juul Labs related to the e vapor market. The lawsuit focuses on alleged anticompetitive practices tied to the sale of Juul pods. Class certification marks a key procedural step that could affect Altria Group's future legal and financial exposure. For investors following Altria Group, NYSE:MO, this legal update arrives while the stock trades at $65.07. Shares are up 13.5% year to date and 20.0% over the...
NasdaqGS:EQPT
NasdaqGS:EQPTTrade Distributors

EquipmentShare (EQPT) Margins Stay Thin As US$3m Profit Tests Bullish Growth Narratives

EquipmentShare.com (EQPT) just closed FY 2025 with fourth quarter revenue of US$1.6b and basic EPS of US$0.68. Trailing 12 month revenue came in at US$4.4b with basic EPS of US$0.04 as the business moved into positive net income territory of US$3m over that period. The company has seen quarterly revenue range from US$776.3m in 2024 Q3 to US$1.6b in 2025 Q4, with basic EPS swinging between a loss of US$0.30 in early 2025 and a profit of US$0.68 in the latest quarter. This leaves investors...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

QuickBooks Desktop Deadline Tests Intuit Retention As Xero Targets Migrations

Intuit (NasdaqGS:INTU) plans to end support for QuickBooks Desktop 2023 on May 31, 2026, creating a firm migration deadline for small businesses. Xendoo and Xero recently announced Q2X, a dedicated migration platform built to help businesses move off QuickBooks, including QuickBooks Desktop. The Q2X launch highlights growing concern across the accounting ecosystem about how companies will handle data, workflows, and continuity as the deadline approaches. For Intuit, whose QuickBooks...
NasdaqGS:FROG
NasdaqGS:FROGSoftware

A Look At JFrog (FROG) Valuation As Longer Term Returns Contrast With Recent Mixed Trading

Context for JFrog after recent trading moves JFrog (FROG) has seen mixed trading recently, with a 0.9% decline over the past day, a 3.7% gain over the past week, and weaker returns over the past month and past 3 months. See our latest analysis for JFrog. At a share price of $43.46, JFrog’s short term momentum has cooled, with a 30 day share price return of 8.63% and a 90 day share price return of 34.95%. Its 1 year total shareholder return of 28.31% and 3 year total shareholder return of...
NYSE:CRS
NYSE:CRSAerospace & Defense

Does New Positive Coverage and CEO Transition Shift the Bull Case for Carpenter Technology (CRS)?

Earlier this week, Carpenter Technology Corporation participated in the JPMorgan Industrials Conference 2026 in Washington, D.C., while investors reacted to fresh analyst coverage and upcoming CEO transition plans. The combination of new brokerage research highlighting Carpenter Technology’s role in advanced aerospace and defense alloys and the planned handover from CEO Tony Thene to COO Brian Malloy has sharpened market attention on how leadership and industry positioning may shape the...
NasdaqCM:SSII
NasdaqCM:SSIIMedical Equipment

A Look At SS Innovations International (SSII) Valuation After Earnings And Auditor Going Concern Warning

SS Innovations International (SSII) drew investor attention after releasing its 2025 results, which combined higher reported revenue with a smaller annual net loss and, at the same time, a going concern warning from auditor BDO LLP. See our latest analysis for SS Innovations International. At a share price of US$5.01, SS Innovations International has seen a 25% 1 month share price return, while the year to date share price return and 1 year total shareholder return remain negative. This hints...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Alvotech (ALVO) TTM Profitability Challenged By Q4 US$108.5 Million Net Loss

FY 2025 earnings snapshot for Alvotech (NasdaqGM:ALVO) Alvotech (NasdaqGM:ALVO) closed FY 2025 with Q4 revenue of US$168.9 million and a basic EPS loss of US$0.44, as net income excluding extra items came in at a loss of US$108.5 million. The company has seen quarterly revenue range from US$102.99 million in Q3 2024 to US$173.3 million in Q2 2025, while basic EPS has swung between a loss of US$0.23 in Q4 2024 and a profit of US$0.39 in Q1 2025. This sets up a year where the trailing twelve...
NasdaqGM:TATT
NasdaqGM:TATTAerospace & Defense

TAT Technologies (TATT) Margin Expansion To 9.4% Tests Bullish Efficiency Narrative

TAT Technologies (NasdaqGM:TATT) has wrapped up FY 2025 with fourth quarter revenue of US$46.5 million and basic EPS of US$0.36, capping a year in which trailing 12 month revenue reached US$178.0 million and EPS came in at US$1.39. Over recent periods the company has seen quarterly revenue move from US$41.0 million in Q4 2024 to US$46.5 million in Q4 2025. Basic EPS was US$0.36 a year ago and US$0.36 this quarter on a quarterly basis, and moved from US$1.08 to US$1.39 on a trailing 12 month...
NasdaqGM:ASST
NasdaqGM:ASSTMedical Equipment

Strive Asset Management (ASST) Q4 US$205.6m Loss Reinforces Bearish Earnings Narratives

Strive Asset Management (ASST) FY 2025 earnings snapshot Strive Asset Management (ASST) has just wrapped up FY 2025 with Q4 total revenue of about US$1.3 million and a loss per share of US$6.17, alongside a net loss excluding extra items of US$205.6 million, setting a stark backdrop for the latest numbers. Over the past year, revenue has moved from roughly US$0.8 million in Q2 2024 to US$1.3 million in Q4 2025, while trailing twelve month EPS shifted from a US$194.99 loss to a US$12.74 loss...